Growth Metrics

Krystal Biotech (KRYS) Net Income (2021 - 2026)

Krystal Biotech's Net Income history spans 6 years, with the latest figure at $55.9 million for Q1 2026.

  • On a quarterly basis, Net Income rose 56.53% to $55.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $225.1 million, a 81.52% increase, with the full-year FY2025 number at $204.8 million, up 129.74% from a year prior.
  • Net Income hit $55.9 million in Q1 2026 for Krystal Biotech, up from $51.4 million in the prior quarter.
  • Over the last five years, Net Income for KRYS hit a ceiling of $80.7 million in Q3 2023 and a floor of -$50.0 million in Q1 2022.
  • Historically, Net Income has averaged $13.0 million across 5 years, with a median of $15.6 million in 2024.
  • Biggest five-year swings in Net Income: crashed 215.99% in 2022 and later surged 3734.01% in 2025.
  • Tracing KRYS's Net Income over 5 years: stood at -$32.1 million in 2022, then skyrocketed by 127.12% to $8.7 million in 2023, then surged by 423.62% to $45.5 million in 2024, then grew by 12.93% to $51.4 million in 2025, then rose by 8.82% to $55.9 million in 2026.
  • Business Quant data shows Net Income for KRYS at $55.9 million in Q1 2026, $51.4 million in Q4 2025, and $79.4 million in Q3 2025.